Public Company News

BrightGene Announces Positive Topline Phase 1 Results of Oral BGM0504 in Obesity in China and the United States

BGM0504 shown to be generally well tolerated Overall safety, pk, and efficacy profile supports once-daily oral dosing SUZHOU, China, March 25, 2026 /PRNewswire/ -- BrightGene Bio-Medical Technology Co., Ltd. (SSE: 688166, "BrightGene" or "the Company") today announced positive topline results f...

2026-03-25 14:32 4595

Akeso Advances "IO 2.0 + ADC 2.0" Strategy with Phase II Initiation of Novel ADCs Combined with Ivonescimab and Cadonilimab

HONG KONG, March 24, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK)  ("Akeso" or the "Company") announced today that it has received clearance from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) to initiate Phase II clinical trials for AK146D1, a first...

2026-03-25 10:40 6256

Hanwha Power Systems and PSM unite as Hanwha Power, a global compressor and gas turbine business

The combined company will accelerate its expansion into global energy markets, including power plants and data centers. SEOUL, South Korea, March 24, 2026 /PRNewswire/ -- Hanwha Impact's subsidiaries, Hanwha Power Systems and PSM (Power Systems Mfg., LLC), a U.S.-based gas turbine service compan...

2026-03-25 08:23 6391

Paranovus Entertainment Technology Limited Announces Pricing of $5 Million Registered Direct Offering At-The-Market Under NASDAQ Rules

NEW YORK, March 24, 2026 /PRNewswire/ -- Paranovus Entertainment Technology Limited (NASDAQ: PAVS) today announced that it has entered into a definitive agreement with a single institutional investor for a registered direct offering priced at-the-market under Nasdaq Rules of an aggregate of 14,28...

2026-03-25 03:09 5962

Fosun Pharma Announces 2025 Annual Results

Innovation and Globalization Propel Fosun Pharma's High-Quality Growth SHANGHAI, March 24, 2026 /PRNewswire/ -- On 24 March, 2026, Fosun Pharma ("the company", stock code: 600196.SH; 02196.HK), an innovation-driven global pharmaceutical and healthcare group, announced its 2025 annual operating r...

2026-03-24 22:47 5589

Datasea (NASDAQ: DTSS) Announces Initial U.S. Commercial Rollout and Commercialization Pathway for Acoustic Technology-Enabled Wellness Care Robots

Early-stage deployments across multiple U.S. regions expected to support initial service revenue generation and scalable commercialization model BEIJING, March 24, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company specializing in acoustic high-te...

2026-03-24 21:30 5975

E-Home Household Services Holdings Limited has recently won bids for several community service centers, with the total value of the newly added services amounting to approximately 5 million RMB

FUZHOU, China, March 24, 2026 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider in China, announced today that the new spring company has signed domestic cleaning service agreements with multiple community heal...

2026-03-24 21:00 4401

Ping An Good Doctor Reports 2025 Annual Results: Corporate Health Management Business Posts Strong Growth; AI Healthcare Deployment Accelerates

HONG KONG, March 24, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or the "Company"; Stock Code: 1833.HK) announced its annual results for the year ended December 31, 2025. In 2025, the Company recorded total revenue of RMB5.47 billion, up 13.7% yea...

2026-03-24 20:37 5583

Erayak Power Solution Strategic Update: Accelerating High-Capacity UPS-Integrated Platforms to Support AI-Driven Energy Demand

Prototype preview expected at the 2026 National Hardware Show as Ruike Electronics facility advances WENZHOU, China, March 24, 2026 /PRNewswire/ -- Erayak Power Solution Group Inc. (Nasdaq: RAYA) ("Erayak" or the "Company"), a developer and manufacturer of portable power equipment, today announc...

2026-03-24 20:05 4979

WuXi Biologics Reports Record 2025 Annual Results

* Revenue increased 16.7% YoY to RMB 21.8 billion, and revenue from continuous operations grew over 20% YoY * IFRS gross profit margin expanded to 46.0% (+500 bps YoY); adjusted gross profit margin increased to 48.8% (+340bps) * EBITDA rose 38.1% YoY and IFRS net profit increased 45.3% YoY; ...

2026-03-24 19:44 6115

Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer

Appointments Reinforce Deep Technical Expertise in Biotech R&D and Capital Markets Leadership as Origin Advances Its Commercial Pipeline BEIJING, March 24, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, tod...

2026-03-24 19:30 3839

LightInTheBox Reports Fourth Quarter and Full Year 2025 Financial Results

Record Full year Profit of $8.3 million Record Quarterly Profit of $3.3 Million Delivers Seventh Consecutive Profitable Quarter Regains Quarterly Revenue Growth SINGAPORE, March 24, 2026 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global consu...

2026-03-24 19:00 7628

Robo.ai Initiates Revenue Recognition for Intelligent Data Business and Advances Tens of Thousands of Hours of Capacity Cooperation Across the Middle East and Asia

DUBAI, UAE, March 24, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ: AIIO) (the "Company" or "Robo.ai") today announced the capacity expansion plan for its intelligent data business segment. Following the delivery of its initial batch of real-world interaction data and the initiation of the revenue r...

2026-03-24 18:57 4635

Insilico Medicine and ASKA Pharmaceutical Expand Partnership to Discover Novel Targets for Women's Health

CAMBRIDGE, Mass., March 24, 2026 /PRNewswire/ -- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced a strategic research collaboration with ASKA Pharmaceutical Co., Ltd. ("ASKA"), a specialized p...

2026-03-24 18:29 4217

GCCL Showcases RSV FRNT Research and Integrated Bioanalytical Capabilities at World Vaccine Congress 2026

YONGIN, South Korea, March 24, 2026 /PRNewswire/ -- GCCL Co., Ltd. (GCCL), a global clinical trial laboratory services provider, announced that it will attend World Vaccine Congress 2026 (WVC 2026), taking place from March 30 to April 2 in Washington, D.C., where it will operate an exhibition boo...

2026-03-24 17:35 3850

Cheetah Mobile Announces Fourth Quarter and Fiscal Year 2025 Unaudited Consolidated Financial Results

AI and Others revenue grew 84.7% year over year and accounted for 46.5% of total revenue in 2025 BEIJING, March 24, 2026 /PRNewswire/ -- Cheetah Mobile Inc. ("Cheetah Mobile" or the "Company") (NYSE: CMCM), a China-based IT company with a commitment to AI innovation, today announced its unaudite...

2026-03-24 16:30 5308

HOY Unveils a Powerhouse Line-up with Cross-Industry Partnerships to Usher in a Bold New Chapter

Exclusive Asian Games Broadcast Continues for Eighth Consecutive Years HONG KONG, March 24, 2026 /PRNewswire/ -- HOY, the free–to–air television channel underi–CABLE Communications Limited (Stock Code: 1097), unveiled its 2026 program slate at FilmArt, marking a major step forward into a compreh...

2026-03-24 15:28 3285

Tuya Smart Launches TuyaClaw--Still the Same "Claw," but Actually Does Housework

NEW YORK, March 24, 2026 /PRNewswire/ -- Tuya Smart (NYSE: TUYA, HKEX: 2391), a global AI cloud platform service provider, has officially launched TuyaClaw, the AI agent that connects the digital and physical worlds. Built on the OpenClaw architecture, it significantly reduces deployment barriers...

2026-03-24 14:10 4681

LEIFRAS Co., Ltd. Releases Two Business Introduction Videos Visualizing "Community Transfer of Club Activities" and "Sports Therapy"

Bringing to Life How Schools, Homes, and Communities Are Changing Across Japan Through Real Insights from the Field TOKYO, March 23, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and community eng...

2026-03-24 09:00 4325

The Phase 3 Registration STAR Study of Efdamrofusp Alfa (IBI302) Met its Primary Endpoint, Making it the First Self-developed Extended-interval Treatment for nAMD in China

* 73% of participants achieved Q16W dosing interval; Furthermore, nearly 60% of the participants held the potential to extend the dosing interval to Q20W. SAN FRANCISCO and SUZHOU, China, March 23, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharma...

2026-03-24 08:00 5341
1 ... 54555657585960 ... 758

Week's Top Stories